Table 1.
EV Category | Name | EV Class | Size (nm) | Markers | Biogenesis |
---|---|---|---|---|---|
Exosomes | Classical | Small | 30–200 | CD63+/CD9+/CD81+ | MVE |
Non-classical | Small | 30–200 | CD63+/CD9+/CD81− | MVE | |
Microvesicle | Classical | Large | 150–1000 | Annexin A1, ARF6 | PMS |
Oncosomes | Large | 1000–10,000 | Annexin A1, ARF6 | PMS | |
ARMM | Small | 40–100 | ARRDC1, TSG101 | PMS | |
Apoptotic | Apoptotic body | Large | 1000–5000 | Annexin V, PS | Apoptosis |
Apoptotic vesicle | Small to large | 100–1000 | Annexin V, P5 | Apoptosis | |
Autophagic | Autophagic EV | Small to large | 40–1000 | LC3B-PE, p62, dsDNA/histones | Amphisome |
Stressed (Stressome) | Stressed EV | Small to large | 40–1000 | HSP90, HSPs | PMS |
Damaged EV | Small to large | 40–1000 | CD63+/CD9+/CD81+ | PMS | |
Matrix vesicles | Matrix vesicles | Small to large | 40–1000 | Fibronectin, Proteoglycan | Matrix binding release |
MVE—multivesicular endosome; ARMM—arrestin-domain-containing protein 1 (ARRDC1)-mediated microvesicle; PMS—plasma membrane shedding; Amphisome—Autophagosome-endosome fusion. Table adapted from Sheta et al. [104].